240 related articles for article (PubMed ID: 11340524)
1. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases.
Reid KC; Cockerill III FR; Patel R
Clin Infect Dis; 2001 Jun; 32(11):1540-6. PubMed ID: 11340524
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases.
Choi SH; Lee SO; Kim TH; Chung JW; Choo EJ; Kwak YG; Kim MN; Kim YS; Woo JH; Ryu J; Kim NJ
Clin Infect Dis; 2004 Jan; 38(1):53-61. PubMed ID: 14679448
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
4. [Bacteremia caused by Enterococcus gallinarum with a high level of glycopeptide resistance: 1st documented cases in Argentina].
Togneri A; Lopardo H; Corso A
Rev Argent Microbiol; 2003; 35(2):96-9. PubMed ID: 12920991
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.
Poh CH; Oh HM; Tan AL
J Infect; 2006 May; 52(5):383-6. PubMed ID: 16203039
[TBL] [Abstract][Full Text] [Related]
6. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
[TBL] [Abstract][Full Text] [Related]
7. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal colonisation of vancomycin-resistant enterococcus in a Singapore teaching hospital.
Oon LL; Ling MM; Chiew YF
Pathology; 2001 May; 33(2):216-21. PubMed ID: 11358057
[TBL] [Abstract][Full Text] [Related]
9. Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation.
Christidou A; Gikas A; Scoulica E; Pediaditis J; Roumbelaki M; Georgiladakis A; Tselentis Y
Clin Microbiol Infect; 2004 Nov; 10(11):999-1005. PubMed ID: 15522003
[TBL] [Abstract][Full Text] [Related]
10. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
Erlandson KM; Sun J; Iwen PC; Rupp ME
Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci.
Contreras GA; DiazGranados CA; Cortes L; Reyes J; Vanegas S; Panesso D; Rincón S; Díaz L; Prada G; Murray BE; Arias CA
J Hosp Infect; 2008 Dec; 70(4):346-52. PubMed ID: 18799242
[TBL] [Abstract][Full Text] [Related]
12. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia.
Al-Otaibi FE; Kambal AM; Baabbad RA
Saudi Med J; 2004 Jan; 25(1):21-5. PubMed ID: 14758373
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia caused by VanC-type enterococci in a university hospital in Japan: a 6-year survey.
Koganemaru H; Hitomi S
J Infect Chemother; 2008 Dec; 14(6):413-7. PubMed ID: 19089554
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia due to motile Enterococcus species: clinical features and outcomes.
Ratanasuwan W; Iwen PC; Hinrichs SH; Rupp ME
Clin Infect Dis; 1999 May; 28(5):1175-7. PubMed ID: 10452665
[No Abstract] [Full Text] [Related]
18. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study.
Anderson DJ; Murdoch DR; Sexton DJ; Reller LB; Stout JE; Cabell CH; Corey GR
Infection; 2004 Apr; 32(2):72-7. PubMed ID: 15057570
[TBL] [Abstract][Full Text] [Related]
19. Colonization with vancomycin-resistant enterococci (VRE) in intensive care unit patients in Cordoba City, Argentina.
Littvik AM; López TN; González SE; Fernández CM; Pavan JV
Rev Argent Microbiol; 2006; 38(1):28-30. PubMed ID: 16784130
[TBL] [Abstract][Full Text] [Related]
20. [Emergency of vancomycin-resistant Enterococcus infections in a teaching hospital in Chile].
Fica A; Jemenao MI; Bilbao P; Ruiz G; Sakurada A; Pérez de Arce E; Zúñiga I; Gompertz M
Rev Chilena Infectol; 2007 Dec; 24(6):462-71. PubMed ID: 18180821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
